Utilization of a CART Pathway: Impact to Length of Stay and Re-Admission Rates

Upon retrospective review of our 2022 Immune Effector Cell (IEC) patients, we identified the opportunity to reduce length of stay (LOS) for the inpatient population. A clinical pathway strategy (Rotter, de Jong RB, Lacko SE, et.al., 2019) was chosen to define a multidisciplinary approach of care for patients admitted to the facility to drive targeted, early discharges after IEC therapy. A multidisciplinary team developed a pathway which spans from referral to discharge back to the referring practice.
Source: Biology of Blood and Marrow Transplantation - Category: Hematology Authors: Tags: 79 Source Type: research